.1mjauleg92t94.webp&w=3840&q=75){kind=logo}
Based on Dr. Christeen's speech at the 16th Abu Dhabi Wound Care Conference (ADWCC) 2025, organized by the IWCG.
Why Diabetic Foot Ulcers Deserve Serious Attention?
Diabetic foot ulcers are among the most serious complications for people with diabetes. These wounds are slow to heal due to poor blood flow and nerve damage, making them prone to infection, long hospital stays, and, in severe cases, amputation. Traditional treatments—like dressings, antibiotics, and debridement—often do not heal these ulcers quickly or completely, especially in chronic cases.
What Is SVF (Stromal Vascular Fraction)?
Stromal Vascular Fraction (SVF) is a mixture of regenerative cells taken from a patient's own fat tissue. SVF contains:
- Mesenchymal stem cells (MSCs) that can become different cell types
- Growth factors that stimulate tissue repair
- Cytokines that regulate immune response
- Other healing-promoting cells
The collection and injection process is quick and minimally invasive. SVF is usually injected around the wound site to support healing.
How SVF Heals Diabetic Foot Ulcers?
SVF works in several ways to encourage wound healing:
- Promotes New Blood Vessels. SVF stimulates angiogenesis (formation of new blood vessels), improving circulation to the wound, a critical factor for healing in diabetic patients.
- Reduces Inflammation. SVF contains immune cells that help reduce chronic inflammation, creating a better environment for healing.
- Regenerates Tissue. SVF activates skin cells, increases collagen production, and supports tissue regeneration, helping wounds close faster and stronger.
- Enhances Oxygen and Nutrient Delivery. Improved blood flow means better oxygen and nutrient delivery, which is essential for tissue repair.
Clinical Evidence: What the Research Says
A major clinical study involving 63 patients with chronic, non-healing diabetic foot ulcers (all at risk of amputation) found that:
- 51 patients achieved full wound closure within 6 months.
- 8 more had at least 75% improvement.
- After one year, 50 maintained complete healing, and 4 showed over 85% closure.
- No serious side effects were reported, even in patients with large ulcers.
- Doppler ultrasound confirmed improved blood flow in treated areas.
- Even wounds over 10 cm² responded positively, showing that SVF works for various ulcer sizes.
These results indicate that SVF can be safely used to treat chronic diabetic foot ulcers, with evidence of efficacy and mechanisms of action that include vascular repair and angiogenesis.
Why SVF Is a Game-Changer
- Minimally Invasive. Uses the patient's fat-derived cells, no surgery or artificial implants.
- Time-Efficient. SVF can be collected and injected in a single outpatient visit.
- Safe and Practical. Suitable for resource-limited settings; does not require hospitalization.
- Targets the Root Cause. SVF improves circulation and promotes regeneration, not just symptom relief.
Key Takeaways for Patients and Caregivers
- SVF therapy is a safe and effective option for chronic, non-healing diabetic foot ulcers.
- It significantly increases healing rates and may help avoid amputation.
- SVF therapy is showing potential to become a new standard in diabetic foot care worldwide.
Frequently Asked Questions (FAQ)
A New Era in Diabetic Wound Healing
SVF therapy offers new hope to patients with diabetic foot ulcers. It is safe, minimally invasive, and backed by scientific evidence. As more clinics adopt this approach, SVF may soon become a standard treatment, helping more people heal and avoid amputation.
